Membrane type 1 matrix metalloproteinase regulates monocyte migration and collagen destruction in tuberculosis

Journal of Immunology

Volumn 195, Issue 3, 2015, Pages 882-891

  Sathyamoorthy, Tarangini ^a   Tezera, Liku B ^b   Walker, Naomi F ^a,c   Brilha, Sara ^a   Saraiva, Luisa ^a   Mauri, Francesco A ^a   Wilkinson, Robert J ^c,d,e   Friedland, Jon S ^a   Elkington, Paul T ^a,b,f  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; COLLAGENASE; G PROTEIN COUPLED RECEPTOR; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; COLLAGEN; MMP14 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; LEUKOCYTE MIGRATION; LUNG ALVEOLUS MACROPHAGE; LUNG GRANULOMA; LUNG INFILTRATE; LUNG TUBERCULOSIS; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; SIGNAL TRANSDUCTION; THORAX RADIOGRAPHY; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; YOUNG ADULT;

ADULT; AGED; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; COLLAGENASES; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 14; MIDDLE AGED; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RNA, MESSENGER; SPUTUM; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84937700469     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403110     Document Type: Article

References (59)

1. World Health Organization. 2014. Global tuberculosis report 2014. Available at: http://www.who.int/tb/publications/global-report/en/. Accessed: December, 12, 2014.
2. Cooper, A. M., and E. Torrado. 2012. Protection versus pathology in tuberculosis: recent insights. Curr. Opin. Immunol. 24: 431-437.
3. Kline, S. E., L. L. Hedemark, and S. F. Davies. 1995. Outbreak of tuberculosis among regular patrons of a neighborhood bar. N. Engl. J. Med. 333: 222-227.
4. Rodrigo, T., J. A. Caylà, P. García de Olalla, H. Galdós-Tangüis, J. M. Jansà, P. Miranda, and T. Brugal. 1997. Characteristics of tuberculosis patients who generate secondary cases. Int. J. Tuberc. Lung Dis. 1: 352-357.
5. Kempker, R. R., A. S. Rabin, K. Nikolaishvili, I. Kalandadze, S. Gogishvili, H. M. Blumberg, and S. Vashakidze. 2012. Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis. Clin. Infect. Dis. 54: e51-e54.
6. Kaplan, G., F. A. Post, A. L. Moreira, H. Wainwright, B. N. Kreiswirth, M. Tanverdi, B. Mathema, S. V. Ramaswamy, G. Walther, L. M. Steyn, et al. 2003. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect. Immun. 71: 7099-7108.
7. Jeon, D. S., D. H. Kim, H. S. Kang, S. H. Hwang, J. H. Min, J. H. Kim, N. M. Sung, M. W. Carroll, and S. K. Park. 2009. Survival and predictors of outcomes in non-HIV-infected patients with extensively drug-resistant tuberculosis. Int. J. Tuberc. Lung Dis. 13: 594-600.
8. Erdogan, A., A. Yegin, G. Gürses, and A. Demircan. 2005. Surgical management of tuberculosis-related hemoptysis. Ann. Thorac. Surg. 79: 299-302.
9. Rhee, C. K., K. H. Yoo, J. H. Lee, M. J. Park,W. J. Kim, Y. B. Park, Y. I. Hwang, Y. S. Kim, J. Y. Jung, J. Y. Moon, et al. 2013. Clinical characteristics of patients with tuberculosis-destroyed lung. Int. J. Tuberc. Lung Dis. 17: 67-75.
10. Vincenti, M. P., and C. E. Brinckerhoff. 2007. Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you? J. Cell. Physiol. 213: 355-364.
11. Volkman, H. E., T. C. Pozos, J. Zheng, J. M. Davis, J. F. Rawls, and L. Ramakrishnan. 2010. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327: 466-469.
12. Itoh, Y., and M. Seiki. 2006. MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell. Physiol. 206: 1-8.
13. Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
14. Hotary, K., E. Allen, A. Punturieri, I. Yana, and S. J. Weiss. 2000. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 149: 1309-1323.
15. Sabeh, F., I. Ota, K. Holmbeck, H. Birkedal-Hansen, P. Soloway, M. Balbin, C. Lopez-Otin, S. Shapiro, M. Inada, S. Krane, et al. 2004. Tumor cell traffic through the extracellular matrix is controlled by the membrane-Anchored collagenase MT1-MMP. J. Cell Biol. 167: 769-781.
16. Filippov, S., G. C. Koenig, T. H. Chun, K. B. Hotary, I. Ota, T. H. Bugge, J. D. Roberts, W. P. Fay, H. Birkedal-Hansen, K. Holmbeck, et al. 2005. MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. J. Exp. Med. 202: 663-671.
17. Elkington, P., T. Shiomi, R. Breen, R. K. Nuttall, C. A. Ugarte-Gil, N. F. Walker, L. Saraiva, B. Pedersen, F. Mauri, M. Lipman, et al. 2011. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J. Clin. Invest. 121: 1827-1833.
18. Mehra, S., B. Pahar, N. K. Dutta, C. N. Conerly, K. Philippi-Falkenstein, X. Alvarez, and D. Kaushal. 2010. Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas. PLoS ONE 5: e12266.
19. Kim, M. J., H. C. Wainwright, M. Locketz, L. G. Bekker, G. B. Walther, C. Dittrich, A. Visser, W. Wang, F. F. Hsu, U. Wiehart, et al. 2010. Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol. Med. 2: 258-274.
20. Walker, N. F., S. O. Clark, T. Oni, N. Andreu, L. Tezera, S. Singh, L. Saraiva, B. Pedersen, D. L. Kelly, J. A. Tree, et al. 2012. Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases. Am. J. Respir. Crit. Care Med. 185: 989-997.
21. Elkington, P. T., J. A. Green, and J. S. Friedland. 2006. Filter sterilization of highly infectious samples to prevent false negative analysis of matrix metalloproteinase activity. J. Immunol. Methods 309: 115-119.
22. Wiggins, H., and J. Rappoport. 2010. An agarose spot assay for chemotactic invasion. Biotechniques 48: 121-124.
23. Tiwari, S., J. A. Askari, M. J. Humphries, and N. J. Bulleid. 2011. Divalent cations regulate the folding and activation status of integrins during their intracellular trafficking. J. Cell Sci. 124: 1672-1680.
24. Garnotel, R., L. Rittié, S. Poitevin, J. C. Monboisse, P. Nguyen, G. Potron, F. X. Maquart, A. Randoux, and P. Gillery. 2000. Human blood monocytes interact with type I collagen through axb2 integrin (CD11c-CD18, gp150-95). J. Immunol. 164: 5928-5934.
25. Mavhu, W., E. Dauya, T. Bandason, S. Munyati, F. M. Cowan, G. Hart, E. L. Corbett, and J. Chikovore. 2010. Chronic cough and its association with TB-HIV co-infection: factors affecting help-seeking behaviour in Harare, Zimbabwe. Trop. Med. Int. Health 15: 574-579.
26. Park, D. Y., J. Y. Kim, K. U. Choi, J. S. Lee, C. H. Lee, M. Y. Sol, and K. S. Suh. 2003. Comparison of polymerase chain reaction with histopathologic features for diagnosis of tuberculosis in formalin-fixed, paraffin-embedded histologic specimens. Arch. Pathol. Lab. Med. 127: 326-330.
27. Osenkowski, P., M. Toth, and R. Fridman. 2004. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J. Cell. Physiol. 200: 2-10.
28. Munshi, H. G., Y. I. Wu, S. Mukhopadhyay, A. J. Ottaviano, A. Sassano, J. E. Koblinski, L. C. Platanias, and M. S. Stack. 2004. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J. Biol. Chem. 279: 39042-39050.
29. Shi, C., and E. G. Pamer. 2011. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11: 762-774.
30. Gálvez, B. G., L. Genís, S. Matías-Román, S. A. Oblander, K. Tryggvason, S. S. Apte, and A. G. Arroyo. 2005. Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/ccl2 and interleukin-8/CXCL8 in endothelial cells during angiogenesis. J. Biol. Chem. 280: 1292-1298.
31. Volpe, E., G. Cappelli, M. Grassi, A. Martino, A. Serafino, V. Colizzi, N. Sanarico, and F. Mariani. 2006. Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis. Immunology 118: 449-460.
32. Maertzdorf, J., J. Weiner, III, H. J. Mollenkopf, T. Bauer, A. Prasse, J. Müller-Quernheim, and S. H. Kaufmann, TBornotTB Network. 2012. Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc. Natl. Acad. Sci. USA 109: 7853-7858.
33. Ong, C. W., P. T. Elkington, and J. S. Friedland. 2014. Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. Am. J. Respir. Crit. Care Med. 190: 9-18.
34. Lee, H., C. M. Overall, C. A. McCulloch, and J. Sodek. 2006. A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis. Mol. Biol. Cell 17: 4812-4826.
35. Kaner, R. J., F. Santiago, and R. G. Crystal. 2009. Up-regulation of alveolar macrophage matrix metalloproteinases in HIV1+ smokers with early emphysema. J. Leukoc. Biol. 86: 913-922.
36. Zheng, T., Z. Zhu, Z. Wang, R. J. Homer, B. Ma, R. J. Riese, Jr., H. A. Chapman, Jr., S. D. Shapiro, and J. A. Elias. 2000. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J. Clin. Invest. 106: 1081-1093.
37. Maisi, P., K. Prikk, R. Sepper, E. Pirilä, T. Salo, J. Hietanen, and T. Sorsa. 2002. Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. APMIS 110: 771-782.
38. Lara-Pezzi, E., M. V. Gómez-Gaviro, B. G. Gálvez, E. Mira, M. A. Iñiguez, M. Fresno, C. Martínez-A, A. G. Arroyo, and M. López-Cabrera. 2002. The hepatitis B virus X protein promotes tumor cell invasion by inducing membranetype matrix metalloproteinase-1 and cyclooxygenase-2 expression. J. Clin. Invest. 110: 1831-1838.
39. Duarte, S., X. D. Shen, C. Fondevila, R. W. Busuttil, and A. J. Coito. 2012. Fibronectin-A4b1 interactions in hepatic cold ischemia and reperfusion injury: regulation of MMP-9 and MT1-MMP via the p38 MAPK pathway. Am. J. Transplant. 12: 2689-2699.
40. Takino, T., H. Miyamori, Y.Watanabe, K. Yoshioka, M. Seiki, and H. Sato. 2004. Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-Activated protein/extracellular signal-related kinase activation and cell migration. Cancer Res. 64: 1044-1049.
41. Tanimura, S., K. Asato, S. H. Fujishiro, and M. Kohno. 2003. Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44. Biochem. Biophys. Res. Commun. 304: 801-806.
42. Cooper, A. M., and S. A. Khader. 2008. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 226: 191-204.
43. Matías-Román, S., B. G. Gálvez, L. Genís, M. Yáñez-Mó, G. de la Rosa, P. Sánchez-Mateos, F. Sánchez-Madrid, and A. G. Arroyo. 2005. Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood 105: 3956-3964.
44. Richardson, V. J. 2010. Divergent and synergistic regulation of matrix metalloprotease production by cytokines in combination with C-C chemokines. Int. J. Immunopathol. Pharmacol. 23: 715-726.
45. Elkington, P. T., J. A. Green, J. E. Emerson, L. D. Lopez-Pascua, J. J. Boyle, C. M. O'Kane, and J. S. Friedland. 2007. Synergistic up-regulation of epithelial cell matrix metalloproteinase-9 secretion in tuberculosis. Am. J. Respir. Cell Mol. Biol. 37: 431-437.
46. Davis, J. M., and L. Ramakrishnan. 2009. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136: 37-49.
47. Antonelli, L. R., A. Gigliotti Rothfuchs, R. Gonc?alves, E. Roffe?, A. W. Cheever, A. Bafica, A. M. Salazar, C. G. Feng, and A. Sher. 2010. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest. 120: 1674-1682.
48. Ramakrishnan, L. 2012. Revisiting the role of the granuloma in tuberculosis. Nat. Rev. Immunol. 12: 352-366.
49. Gingras, D., N. Bousquet-Gagnon, S. Langlois, M. P. Lachambre, B. Annabi, and R. Béliveau. 2001. Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett. 507: 231-236.
50. Shimizu-Hirota, R., W. Xiong, B. T. Baxter, S. L. Kunkel, I. Maillard, X. W. Chen, F. Sabeh, R. Liu, X. Y. Li, and S. J. Weiss. 2012. MT1-MMP regulates the PI3Kd?Mi-2/NuRD-dependent control of macrophage immune function. Genes Dev. 26: 395-413.
51. Chun, T. H., F. Sabeh, I. Ota, H. Murphy, K. T. McDonagh, K. Holmbeck, H. Birkedal-Hansen, E. D. Allen, and S. J. Weiss. 2004. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J. Cell Biol. 167: 757-767.
52. Barbolina, M. V., and M. S. Stack. 2008. Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis. Semin. Cell Dev. Biol. 19: 24-33.
53. Itoh, Y. 2006. MT1-MMP: a key regulator of cell migration in tissue. IUBMB Life 58: 589-596.
54. Belkin, A. M., S. S. Akimov, L. S. Zaritskaya, B. I. Ratnikov, E. I. Deryugina, and A. Y. Strongin. 2001. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J. Biol. Chem. 276: 18415-18422.
55. Deryugina, E. I., B. I. Ratnikov, T. I. Postnova, D. V. Rozanov, and A. Y. Strongin. 2002. Processing of integrin av subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J. Biol. Chem. 277: 9749-9756.
56. Kajita, M., Y. Itoh, T. Chiba, H. Mori, A. Okada, H. Kinoh, and M. Seiki. 2001. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 153: 893-904.
57. Sounni, N. E., D. V. Rozanov, A. G. Remacle, V. S. Golubkov, A. Noel, and A. Y. Strongin. 2010. Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells. Int. J. Cancer 126: 1067-1078.
58. Hawn, T. R., A. I. Matheson, S. N. Maley, and O. Vandal. 2013. Host-directed therapeutics for tuberculosis: can we harness the host? Microbiol. Mol. Biol. Rev. 77: 608-627.
59. Mayer-Barber, K. D., B. B. Andrade, S. D. Oland, E. P. Amaral, D. L. Barber, J. Gonzales, S. C. Derrick, R. Shi, N. P. Kumar, W. Wei, et al. 2014. Hostdirected therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511: 99-103.